Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A one-on-one video interview between our editorial teams and industry leaders.
Listen to expert discussions and interviews in pharma and biopharma.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
Current president Tom Ross is the new chief executive
April 7, 2015
By: Tim Wright
Editor-in-Chief, Contract Pharma
Grand River Aseptic Manufacturing (GRAM) has appointed current president Tom Ross to the position of chief executive officer of the company. Tom first joined Grand River in January 2013 serving as an advisor to the company and shortly thereafter was named president in August 2013. Before coming to Grand River, Mr. Ross spent a good part of his career at Perrigo, a large generic pharmaceutical manufacturer based in Michigan. He quickly rose through the ranks and became the top financial officer on the executive team. While serving in executive roles at Perrigo, the company grew from $300 million to $1 billion. Mr. Ross eventually left Perrigo to start two successful companies of his own. Jerry Arthur, chairman of GRAM said, “Tom’s vision is that the company be a high growth, industry leader in life sciences. With his leadership, intellect and discipline, GRAM is well on its way to making this vision a reality. In his short time at GRAM, Mr. Ross has been able to secure $10 million in investment, opened a finishing facility, and grow the company from 25 employees to over 70 today. This year will be a milestone year for GRAM as the company anticipates explosive growth in 2015.” “It is an honor to lead a team of highly accomplished and skilled associates at GRAM,” said Mr. Ross. “We are very proud that GRAM was formed in Dec. 2010 and in just over four years, we have become FDA approved as a parenteral sterile injectable pharmaceutical company and have secured several large new customers. Our customers depend on GRAM’s adherence to the strictest quality standards to produce safe and effective pharmaceuticals. GRAM’s team continues to expand and we look forward to a very bright future with exceptional growth.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !